Medicare-Medicaid Dual Eligibility for Ryan White HIV/AIDS Program (RWHAP) Clients
Resource updated 03/18/2024
Resource updated 03/18/2024
People aging with HIV are at increased risk and experience an array of comorbidities including diabetes, cardiovascular disease, and neurocognitive impairment. This poster will demonstrate the implementation of Medicare Wellness Visits, outcome data and lessons learned.
Resource (Conference Presentation) updated 09/14/2023
The syndemic of opioid use disorder, HCV and HIV and stigma causes burdens on individuals and the system. Integrating siloed systems of care is critical to addressing this crisis. Overlapping cascades of care are key to understanding the empirical relationships of these diseases and opportunities to identify, prevent and co-treat.
Resource (Conference Presentation) updated 09/14/2023
Max Clinic's multi-agency partnership to address the complex medical and social needs of people with HIV by utilizing a multidisciplinary approach involving case management, field work, and comprehensive medical services to reach people with HIV who are not currently engaged in HIV care.
Resource (Conference Presentation) updated 09/14/2023
Resource updated 05/15/2024
Resource from the RWHAP Best Practices Compilation updated on 11/27/2023
Resource updated 10/23/2023
Resource updated 11/08/2023
Doub elijibilite Medicare-Medicaid la kapab yon sijè konplèks ki gen anpil niyans. Zouti sa a se pou ede moun ki enfekte ak VIH konprann fondman elijibilite ak pwoteksyon asirans lan, avantaj inik ki genyen lè moun doubman elijib pou toulede pwogram yo, ansanm ak kijan Pwogram Ryan White VIH/SIDA (RWHAP) a kapab sipòte kliyan ki doubman elijib yo.
Zouti sa a abòde:
Resource updated 01/10/2024
La doble elegibilidad para Medicare-Medicaid puede ser un asunto complejo con muchas particularidades. Este recurso fue preparado con la intención de ayudar a las personas con VIH a entender los aspectos básicos relativos a la elegibilidad y la cobertura, los beneficios particulares de ser doblemente elegible para ambos programas, y cómo el Programa Ryan White contra el VIH/SIDA (RWHAP, por sus siglas en inglés) puede apoyar a los usuarios con doble elegibilidad.
Este recurso cubre los siguientes aspectos:
Resource updated 01/10/2024
Resource updated 10/30/2023
Resource updated 10/30/2023
Resource from the RWHAP Best Practices Compilation updated on 01/03/2024
Medicare-Medicaid dual eligibility can be a complex topic with many nuances.
This tool is intended to help people with HIV understand the basics of eligibility and coverage, the unique benefits of being dually eligible for both programs, as well as how the Ryan White HIV/AIDS Program (RWHAP) can support dually eligible clients.
This tool covers:
Resource updated 01/12/2024
Clinical care guides for various populations (based upon their racial, ethnic, and gender characteristics) and specific conditions.
Resource updated 09/19/2023
NASTAD’s National AIDS Drug Assistance Program (ADAP) Formulary Database provides an online, searchable, publicly available resource detailing state-by-state ADAP coverage of medications, including HIV antiretroviral (ARV) treatments, “A1” Opportunistic Infections (A1 OI) medications, treatments for hepatitis B and C, mental health and substance use treatment medications, and various vaccines and laboratory tests.
Resource updated 03/07/2024
Resource updated 03/13/2024
Resource updated 06/03/2024
Resource from the RWHAP Best Practices Compilation updated on 06/21/2024
U.S. HIV-related treatment guidelines, drug database, and glossary.
Resource updated 09/20/2023